Apolipoprotein E promotes the binding and uptake of beta-amyloid into Chinese hamster ovary cells in an isoform-specific manner.

No abstract is available for this paper.

• Publication year

  1999

• Venue

  Neuroscience

• Publication date

  1999-06-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/S0306-4522(98)00561-2PMID 10338292
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Proteolytic Degradation of Alzheimer's Disease Amyloid β‐Peptide by a Metalloproteinase from Microglia Cells

  1998cited by this paper
• β‐Amyloid Peptides Increase the Binding and Internalization of Apolipoprotein E to Hippocampal Neurons

  1998cited by this paper
• Overexpression of Hepatic Lipase in Transgenic Mice Decreases Apolipoprotein B-containing and High Density Lipoproteins

  1998cited by this paper
• Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease. A meta-analysis. APOE and Alzheimer Disease Meta Analysis Consortium.

  1997cited by this paper
• Preferential adsorption, internalization and resistance to degradation of the major isoform of the Alzheimer's amyloid peptide, A beta 1-42, in differentiated PC12 cells.

  1997cited by this paper
• Effects of Age, Sex, and Ethnicity on the Association Between Apolipoprotein E Genotype and Alzheimer Disease: A Meta-analysis

  1997cited by this paper
• Characterization of the Binding of Amyloid‐β Peptide to Cell Culture‐Derived Native Apolipoprotein E2, E3, and E4 Isoforms and to Isoforms from Human Plasma

  1997cited by this paper
• Microglial cells internalize aggregates of the Alzheimer's disease amyloid beta-protein via a scavenger receptor.

  1996cited by this paper
• Apolipoprotein E allele–specific antioxidant activity and effects on cytotoxicity by oxidative insults and β–amyloid peptides

  1996cited by this paper
• Microglial Cells Internalize Aggregates of the Alzheimer's Disease Amyloid β-Protein Via a Scavenger Receptor

  1996cited by this paper
• The E280A presenilin 1 Alzheimer mutation produces increased Aβ42 deposition and severe cerebellar pathology

  1996cited by this paper
• Rapid cellular uptake of Alzheimer amyloid βA4 peptide by cultured human neuroblastoma cells

  1996cited by this paper
• Secreted amyloid β–protein similar to that in the senile plaques of Alzheimer's disease is increased in vivo by the presenilin 1 and 2 and APP mutations linked to familial Alzheimer's disease

  1996cited by this paper
• Alzheimer Amyloid-β Peptide Forms Denaturant-Resistant Complex with Type ε3 but Not Type ε4 Isoform of Native Apolipoprotein E

  1996cited by this paper
• Secreted amyloid beta-protein similar to that in the senile plaques of Alzheimer's disease is increased in vivo by the presenilin 1 and 2 and APP mutations linked to familial Alzheimer's disease.

  1996cited by this paper
• Native complex formation between apolipoprotein E isoforms and the Alzheimer's disease peptide A beta.

  1996cited by this paper
• Amyloid beta protein (A beta) removal by neuroglial cells in culture.

  1995cited by this paper
• LDL receptor-related protein, a multifunctional ApoE receptor, binds secreted beta-amyloid precursor protein and mediates its degradation.

  1995cited by this paper
• Amyloid β protein (Aβ) removal by neuroglial cells in culture

  1995cited by this paper
• ApoE genotypes in Australia: roles in early and late onset Alzheimer's disease and Down's syndrome

  1995cited by this paper
• Purification of Apolipoprotein E Attenuates Isoform-specific Binding to -Amyloid (*)

  1995cited by this paper
• Isoform-specific binding of apolipoprotein E to beta-amyloid.

  1994cited by this paper
• Apolipoprotein E, epsilon 4 allele as a major risk factor for sporadic early and late-onset forms of Alzheimer's disease: analysis of the 19q13.2 chromosomal region.

  1994cited by this paper
• Lactoferrin binding to heparan sulfate proteoglycans and the LDL receptor-related protein. Further evidence supporting the importance of direct binding of remnant lipoproteins to HSPG.

  1994cited by this paper
• Association of apolipoprotein E4 with sporadic Alzheimer's disease is more pronounced in early onset type.

  1994cited by this paper
• Confirmation that familial clustering and age of onset in late onset Alzheimer's disease are determined at the apolipoprotein E locus.

  1994cited by this paper
• A high frequency of apolipoprotein E4 isoprotein in Japanese patients with late-onset nonfamilial Alzheimer's disease.

  1993cited by this paper
• Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families.

  1993cited by this paper
• The carboxy terminus of the beta amyloid protein is critical for the seeding of amyloid formation: implications for the pathogenesis of Alzheimer's disease.

  1993cited by this paper
• Apolipoprotein E in sporadic Alzheimer's disease: allelic variation and receptor interactions.

  1993cited by this paper
• Apolipoprotein E ∈4 allele distributions in late-onset Alzheimer's disease and in other amyloid-forming diseases

  1993cited by this paper
• The apolipoprotein ε4 allele in patients with Alzheimer's disease

  1993cited by this paper
• Apolipoprotein E: high-avidity binding to beta-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease.

  1993cited by this paper
• Role of heparan sulfate proteoglycans in the binding and uptake of apolipoprotein E-enriched remnant lipoproteins by cultured cells.

  1993cited by this paper
• Apolipoprotein E: a pathological chaperone protein in patients with cerebral and systemic amyloid.

  1992cited by this paper
• Apolipoprotein E immunoreactivity in cerebral amyloid deposits and neurofibrillary tangles in Alzheimer's disease and kuru plaque amyloid in Creutzfeldt-Jakob disease.

  1991cited by this paper
• Synthetic Polypeptides As Antigens

  1988cited by this paper
• Alzheimer's disease: Initial report of the purification and characterization of a novel cerebrovascular amyloid protein

  1984cited by this paper

• An in-silico insight into the predictive interaction of Apolipoprotein-E with Epstein-Barr virus proteins and their probable role in mediating Alzheimer’s disease

  2022cites this paper
• Polymeric Nanoparticles Properties and Brain Delivery

  2021cites this paper
• Liver X Receptor Activation with an Intranasal Polymer Therapeutic Prevents Cognitive Decline without Altering Lipid Levels

  2021cites this paper
• Distinct patterns of apolipoprotein C-I, C-II and C-III isoforms are associated with markers of Alzheimer's disease.

  2020cites this paper
• Distinct patterns of apolipoprotein C-I, C-II, and C-III isoforms are associated with markers of Alzheimer’s disease

  2020cites this paper
• Low Density Receptor-Related Protein 1 Interactions With the Extracellular Matrix: More Than Meets the Eye

  2019cites this paper
• Fat and Lipid Metabolism and the Involvement of Apolipoprotein E in Alzheimer's Disease

  2019cites this paper
• Vascular Dysfunction in Alzheimer’s Disease: A Prelude to the Pathological Process or a Consequence of It?

  2019cites this paper
• Alzheimer’s Disease: A Journey from Amyloid Peptides and Oxidative Stress, to Biomarker Technologies and Disease Prevention Strategies—Gains from AIBL and DIAN Cohort Studies

  2018cites this paper
• Insulin resistance is associated with reductions in specific cognitive domains and increases in CSF tau in cognitively normal adults

  2017cites this paper
• Role of LRP1 in the pathogenesis of Alzheimer’s disease: evidence from clinical and preclinical studies

  2017cites this paper
• Series : ApoE and Lipid Homeostasis in Alzheimer ’ s Disease Role of LRP 1 in the pathogenesis of Alzheimer ’ s disease : evidence from clinical and preclinical studies

  2017cites this paper
• Instructions for use Title Coordinated increase of γ-secretase reaction products in the plasma of some female Japanese sporadic Alzheimer ' s disease patients : quantitative analysis of p 3-Alcα with a new ELISA system

  2016cites this paper
• Altered adult neurogenesis in a mouse model of human tauopathy

  2015cites this paper
• Role of apolipoprotein E polymorphism as a prognostic marker in traumatic brain injury and neurodegenerative disease: a critical review.

  2015cites this paper
• Metals and cholesterol: two sides of the same coin in Alzheimer’s disease pathology

  2014cites this paper
• Clearing the amyloid in Alzheimer's: progress towards earlier diagnosis and effective treatments - an update for clinicians.

  2014cites this paper
• Modulating Amyloid Beta Clearance by Altering Cellular and Whole Brain Apolipoprotein E Metabolism

  2014cites this paper
• Plasma insulin-degrading enzyme: Characterisation and evaluation as a potential biomarker for Alzheimer's disease

  2014cites this paper
• The potential applications of Apolipoprotein E in personalized medicine

  2014cites this paper
• Interactions between Apo E and amyloid beta and their relationship to nutriproteomics and neurodegeneration

  2014cites this paper
• Human APOE genotype affects intraneuronal Aβ1-42 accumulation in a lentiviral gene transfer model.

  2014cites this paper
• Amyloid-β oligomers reduces glutamatergic transmission and inhibits synaptic plasticity with underlying mechanisms suggestting akap150 modulates diverse synaptic functions

  2014cites this paper
• Implication du récepteur LSR (lipolysis stimulated lipoprotein receptor) dans le contrôle de l’homéostasie du cholestérol cérébral et les capacités cognitives au cours du vieillissement

  2014cites this paper
• Toward the treatment and prevention of Alzheimer's disease: rational strategies and recent progress.

  2013cites this paper
• A Multifaceted Role for apoE in the Clearance of Beta-Amyloid across the Blood-Brain Barrier

  2012cites this paper
• Functional interactions between peroxisome proliferator-activated receptor-gamma and polipoprotein E isoforms in the regulation of neural functions in models of insulin resistance-relevance to Alzheimer's disease

  2012cites this paper
• Apolipoprotein E and apolipoprotein E receptors: normal biology and roles in Alzheimer disease.

  2012cites this paper
• Roles in Alzheimer Disease Apolipoprotein E and Apolipoprotein E Receptors : Normal Biology and Subject Collection The Biology of Alzheimer Disease Animal Models of Alzheimer Disease

  2012cites this paper
• Influence of LRP-1 and Apolipoprotein E on Amyloid-β Uptake and Toxicity to Cerebrovascular Smooth Muscle Cells

  2012cites this paper
• Studies on the use of glycosaminoglycans for the treatment of Alzheimer ’ s disease

  2012cites this paper
• Yeast as a Model for Studying A Aggregation, Toxicity and Clearance

  2011cites this paper
• Aβ Internalization by Neurons and Glia

  2011cites this paper
• A putative role for PCSK9 in synaptic remodelling and plasticity in response to brain injury: implications for Alzheimer's disease

  2011cites this paper
• Coordinated increase of γ-secretase reaction products in the plasma of some female Japanese sporadic Alzheimer's disease patients: quantitative analysis of p3-Alcα with a new ELISA system

  2011cites this paper
• Human apoE Isoforms Differentially Regulate Brain Amyloid-β Peptide Clearance

  2011cites this paper
• Data-driven modeling of Alzheimer disease pathogenesis.

  2011cites this paper
• Overview of CNS Neuropharmaceuticals

  2011cites this paper
• The Aβ oligomer hypothesis for synapse failure and memory loss in Alzheimer's disease.

  2011cites this paper
• Author ' s personal copy Data-driven modeling of Alzheimer Disease pathogenesis

  2011cites this paper
• The Role of Apolipoprotein E Concentration and Isoform in Amyloid-beta Metabolism In Vivo

  2011cites this paper
• Extensive proteomic screening identifies the obesity-related NYGGF4 protein as a novel LRP1-interactor, showing reduced expression in early Alzheimer's disease

  2010cites this paper
• Identification of the regulatory mechanisms and factors involved in the brain-specific expression of CYP46A1

  2010cites this paper
• APOE and cholesterol homeostasis in Alzheimer's disease.

  2010cites this paper
• Apolipoproteins in the brain: implications for neurological and psychiatric disorders

  2010cites this paper
• Universidade de Lisboa

  2010cites this paper
• APOE Genotype Results in Differential Effects on the Peripheral Clearance of Amyloid-β42 in APOE Knock-in and Knock-out Mice

  2010cites this paper
• Insulin resistance is associated with the pathology of Alzheimer disease

  2010cites this paper
• The role of apolipoprotein E in Alzheimer's disease.

  2009cites this paper
• Amyloid Beta Transport and Effects on Permeability in a Human Brain Endothelial Cell Line

  2009cites this paper
• Haptoglobin binds the antiatherogenic protein apolipoprotein E – impairment of apolipoprotein E stimulation of both lecithin:cholesterol acyltransferase activity and cholesterol uptake by hepatocytes

  2009cites this paper
• Gene expression profile of the PDAPP mouse model for Alzheimer's disease with and without Apolipoprotein E.

  2009cites this paper
• Impact of 27-Hydroxycholesterol on Amyloid-β Peptide Production and ATP-Binding Cassette Transporter Expression in Primary Human Neurons

  2009cites this paper
• The role of glycogen synthase kinase 3 in the early stages of Alzheimers’ disease

  2008cites this paper
• LDL receptor-related protein 1: unique tissue-specific functions revealed by selective gene knockout studies.

  2008cites this paper
• Infection and Alzheimer's Disease: The APOE ε4 Connection and Lipid Metabolism

  2008cites this paper
• HIV-1 TAT inhibits microglial phagocytosis of Abeta peptide.

  2008cites this paper
• Functional role of lipoprotein receptors in Alzheimer's disease.

  2008cites this paper
• Apolipoprotein E: Structural and Functional Interactions with Amyloid β

  2008cites this paper
• Original Article HIV-1 TAT Inhibits Microglial Phagocytosis of Aβ Peptide

  2008cites this paper
• The role of oxidative stress and cholesterol in animal models of Alzheimer's disease

  2008cites this paper
• Alzheimer's Disease : Advances in Genetics, Molecular and Cellular Biology

  2007cites this paper
• Role of A β Transport and Clearance in the Pathogenesis and Treatment of Alzheimer’s Disease

  2007cites this paper
• Cholesterol and β -Amyloid

  2007cites this paper
• Low‐density lipoprotein receptor‐related protein promotes amyloid precursor protein trafficking to lipid rafts in the endocytic pathway

  2007cites this paper
• ApoE and Aβ1–42 interactions

  2007cites this paper
• Internalization of β-Amyloid Peptide by Primary Neurons in the Absence of Apolipoprotein E*

  2007cites this paper
• Phagocytic functions of microglial cells in the central nervous system and their importance in two neurodegenerative diseases: multiple sclerosis and Alzheimer’s disease

  2006cites this paper
• Apolipoprotein E, cholesterol metabolism, diabetes, and the convergence of risk factors for Alzheimer's disease and cardiovascular disease

  2006cites this paper
• Is the LDL Receptor Involved in Cortical Amyloid Protein Clearance?

  2006cites this paper
• Amyloid β peptide as a physiological modulator of neuronal ‘A’-type K+ current

  2006cites this paper
• A deficit in astroglial organization causes the impaired reactive sprouting in human apolipoprotein E4 targeted replacement mice.

  2006cites this paper
• Amyloid beta peptide as a physiological modulator of neuronal 'A'-type K+ current.

  2006cites this paper
• Production and characterization of astrocyte-derived human apolipoprotein E isoforms from immortalized astrocytes and their interactions with amyloid-beta.

  2005cites this paper
• Is there a relation between APOE expression and brain amyloid load in Alzheimer’s disease?

  2005cites this paper
• Alzheimer's disease amyloid-beta peptide modulates apolipoprotein E isoform specific receptor binding

  2005cites this paper
• Hormonal and non-hormonal factors associated with cognition in post-menopausal women

  2004cites this paper
• APOLIPOPROTEIN E AND ITS RECEPTORS : common roles in development and dementia ?

  2004cites this paper
• Midkine and pleiotrophin in neural development and cancer.

  2004cites this paper
• ApoE and clusterin cooperatively suppress Abeta levels and deposition: evidence that ApoE regulates extracellular Abeta metabolism in vivo.

  2004cites this paper
• ApoE and Abeta1-42 interactions: effects of isoform and conformation on structure and function.

  2004cites this paper
• Uptake of Abeta 1-40- and Abeta 1-42-coated yeast by microglial cells: a role for LRP.

  2004cites this paper
• Effects of apolipoprotein E on the human immunodeficiency virus protein tat in neuronal cultures and synaptosomes

  2004cites this paper
• Uptake of Aβ 1–40‐ and Aβ 1–42‐coated yeast by microglial cells: a role for LRP

  2004cites this paper
• ApoE and Clusterin Cooperatively Suppress Aβ Levels and Deposition: Evidence that ApoE Regulates Extracellular Aβ Metabolism In Vivo

  2004cites this paper
• The allelic modulation of apolipoprotein E expression by oestrogen: potential relevance for Alzheimer’s disease

  2004cites this paper
• Alzheimer's disease: the cholesterol connection

  2003cites this paper
• Apolipoprotein E influences amyloid-beta clearance from the murine periphery

  2003influential citation
• Expanding the association between the APOE gene and the risk of Alzheimer's disease: possible roles for APOE promoter polymorphisms and alterations in APOE transcription

  2003cites this paper
• Medicinal chemistry approaches for the treatment and prevention of Alzheimer's disease

  2003cites this paper
• Molecular and Cellular Basis for Anti-Amyloid Therapy in Alzheimer Disease

  2003cites this paper
• Cholesterol Trafficking and Amyloid Beta Peptides

  2003cites this paper
• Reduction of inclusion body pathology in ApoE-deficient mice fed a combination of antioxidants.

  2003cites this paper
• Apolipoprotein D levels are elevated in prefrontal cortex of subjects with Alzheimer's disease: no relation to apolipoprotein E expression or genotype.

  2003cites this paper
• Medicinal ChemistryApproaches for theTreatment and Prevention of Alzheimer's Disease

  2003cites this paper
• Apolipoprotein E enhances uptake of soluble but not aggregated amyloid‐β protein into synaptic terminals

  2003cites this paper
• Neurohormonal Signalling Pathways and the Regulation of Alzheimer β-Amyloid Metabolism Integrating Basic and Clinical Observations for Developing Successful Strategies to Delay, Retard or Prevent Cerebral Amyloidosis in Alzheimer’s Disease

  2002cites this paper
• Mature Glycosylation and Trafficking of Nicastrin Modulate Its Binding to Presenilins* 210

  2002cites this paper
• Apolipoproteins and aging: emerging mechanisms.

  2002cites this paper
• Pharmacological concentrations of the HMG-CoA reductase inhibitor lovastatin decrease the formation of the Alzheimer beta-amyloid peptide in vitro and in patients.

  2002cites this paper